Caffyns PLC (CFYN)
London Exchange · UK · prices in GBX · close of 22 Oct 2026
Key indicators
| Last close | GBX 485.00 |
|---|---|
| 52-week range | 4.15 – 550.00 |
| Return, 1 month / 3 months | −3.0% / +10.2% |
| Return, 1 year / 3 years | −0.6% / −1.3% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 46 |
| Volatility (1 year) | 1,129.0% |
| Worst drawdown (1 year) | -99.2% |
| Average daily value traded | 0.33M GBX |
| Dividend yield | 2.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Caffyns PLC is a motor dealership group based in Eastbourne, England. It runs franchised car showrooms that represent several vehicle brands, offering new and used cars to private and business customers. Alongside vehicle sales, the company provides servicing, parts and accident repair services through its workshops and bodyshops. Its customers are mainly motorists and fleet operators in southern England, and the business has stayed in the same family line for generations.
On this site Caffyns PLC appears as a stock on the London Exchange (UK), code CFYN, with prices in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Caffyns PLC (CFYN) trades on the London Exchange in UK. It last closed at GBX 485.00 on 22 October 2026.
Its price-based Market X-Ray is 48 out of 100 (a weak price profile), ranking 2,173 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 0.6% and over the last three months it rose 10.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 80 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 15.5% | ||
| From 52-week high | -11.0% | ||
| Momentum | 70 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 10.2% | ||
| 6-month return | 22.8% | ||
| 12-month return, skipping the last month | 2.5% | ||
| Stability (higher is calmer) | 1 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 1,129.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -99.2% | ||
| Liquidity | 29 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.33M GBX | ||
| Zero-volume days | 55.0% | ||
| Income | 60 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.1% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | −3.0% |
| 3 months | +10.2% |
| 6 months | +22.8% |
| 1 year | −0.6% |
| 3 years | −1.3% |
| 5 years | +13.2% |
Signals
| 50-day / 200-day average | 487.50 / 419.76 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 17.98 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 9 Jul 2026 | GBP 0.0500 |
| 11 Dec 2025 | GBP 0.0500 |
| 10 Jul 2025 | GBP 0.0500 |
| 12 Dec 2024 | GBP 0.0500 |
| 11 Jul 2024 | GBP 0.0500 |
| 14 Dec 2023 | GBP 0.0500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.